GLP-1 Drug Efficacy and Safety for Weight Management: Comprehensive Review
Comprehensive review of GLP-1 drug efficacy and safety for weight management covers semaglutide, liraglutide, and emerging agents with real-world outcome data.
Quick Facts
What This Study Found
Comprehensive review of GLP-1 drug efficacy and safety for weight management covers semaglutide, liraglutide, and emerging agents with real-world outcome data.
Key Numbers
Meta-analysis pooled all available studies. Drugs evaluated: primarily liraglutide and semaglutide.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Comprehensive review of GLP-1 drug efficacy and safety for weight management covers semaglutide, lir
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis.
- Published In:
- Obesity surgery, 35(5), 1947-1960 (2025)
- Authors:
- Arrowaili, Arief
- Database ID:
- RPEP-09988
Evidence Hierarchy
Combines results from multiple studies to find an overall pattern.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Comprehensive review of GLP-1 drug efficacy and safety for weight management covers semaglutide, liraglutide, and emerging agents with real-world outcome data.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09988APA
Arrowaili, Arief. (2025). Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis.. Obesity surgery, 35(5), 1947-1960. https://doi.org/10.1007/s11695-025-07856-y
MLA
Arrowaili, Arief. "Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis.." Obesity surgery, 2025. https://doi.org/10.1007/s11695-025-07856-y
RethinkPeptides
RethinkPeptides Research Database. "Efficacy and Safety of GLP- 1 Receptor Agonists in the Manag..." RPEP-09988. Retrieved from https://rethinkpeptides.com/research/arrowaili-2025-efficacy-and-safety-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.